This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Note: First published in The Intellectual Property Strategist and Law.com. Artificial intelligence is changing industry and society, and metrics at the US Patent and Trademark Office (USPTO) reflect its impact. See “Inventing AI, Tracing the diffusion of artificial intelligence with U.S. Part One can be viewed here. Part Two. “No
Patents for new therapeutic compounds do not necessarily require disclosure of the discovery process and instead general focus on the properties and synthesis protocols for the compound. The key legal test is whether a skilled person could perform the invention. chemical identity) of its clinical candidates.
Note: First published in The Intellectual Property Strategist and Law.com. Artificial intelligence is changing industry and society, and metrics at the US Patent and Trademark Office (USPTO) reflect its impact. See “Inventing AI, Tracing the diffusion of artificial intelligence with U.S. Part One can be viewed here. Part Three.
Note: First published in The Intellectual Property Strategist and Law.com. Artificial intelligence is changing industry and society, and metrics at the US Patent and Trademark Office (USPTO) reflect its impact. See “Inventing AI, Tracing the diffusion of artificial intelligence with U.S. Generic Machine Learning Algorithm”.
While there are many allegations about the depleting patent quality of EPO patents, the EPO has steadfastly maintained that it is considered the gold standard for patent quality. – The patent system needs complete searches and substantive examination for functioning well. In Agfa NV & Anr.
An invention becomes patentable when it is novel, has an inventive step or is non-obvious. In order to determine whether a particular invention satisfies these preconditions set forth under the Patents Act 1970, it is imperative that an applicant carries out a thorough patent search.
Filing a patent application first requires an invention. An invention includes both (1) conception and (2) reduction to practice. Conception is the formation, in the mind of the inventor, of a definite and permanent idea of a complete and operative invention. Solvay S.A. Honeywell International , 742 F.3d For example.
However, such a strategy may ultimately cost more in the long run, including possibly costing valuable patent protection. What is a Provisional Patent Application? A provisional patent application allows a patent applicant to reserve priority in an invention before committing to the full utility patent application process.
Micro entity status is a newer status, introduced under the America Invents Act Leahy-Smith America Invents Act (“AIA”) in 2011 as an effort to reduce the cost of patenting for small businesses and individual inventors. At Founders Legal, we offer a variety of cost-efficient patent services for clients of all sizes.
Note: First published in The Intellectual Property Strategist and Law.com. Artificial intelligence is changing industry and society, and metrics at the US Patent and Trademark Office (USPTO) reflect its impact. See “Inventing AI, Tracing the diffusion of artificial intelligence with U.S. Part One can be viewed here.
Note: First published in The Intellectual Property Strategist and Law.com. Artificial intelligence is changing industry and society, and metrics at the US Patent and Trademark Office (USPTO) reflect its impact. See “Inventing AI, Tracing the diffusion of artificial intelligence with U.S. Part One can be viewed here.
Note: First published in The Intellectual Property Strategist and Law.com. Artificial intelligence is changing industry and society, and metrics at the US Patent and Trademark Office (USPTO) reflect its impact. See “Inventing AI, Tracing the diffusion of artificial intelligence with U.S. 2020-005406 (PTAB Feb.
Copyright Office has published “ Copyright Registration Guidance: Works Containing Material Generated by Artificial Intelligence ,” which provides that “[i]n the Office’s view, it is well-established that copyright can protect only material that is the product of human creativity. .” For example, the U.S.
Patent and Trademark Office (USPTO), Kathi Vidal, to provide guidance on AI’s role in patent inventorship and support for patent practitioners. This comes amidst a backdrop where AI models currently cannot be recognized as inventors, a stance reaffirmed in the Federal Circuit decision Thaler v.
Jocelyn Bosse explained T 0425/23 concerning issues of insufficiency of disclosure, novelty, and inventive step. The disputes centred around a European patent filed by Impossible Foods Inc., The 7th edition of the IPKat Book of the Year Awards will recognize and celebrate the best IP books published in 2024.
Specifically: AI Inventorship: The Executive Order mandates the USPTO Director to publish, by the end of February 2024, guidance to the USPTO’s patent examiners and applicants addressing inventorship and the utilization of AI, including generative AI, in the inventive process.
Specifically: AI Inventorship: The Executive Order mandates the USPTO Director to publish, by the end of February 2024, guidance to the USPTO’s patent examiners and applicants addressing inventorship and the utilization of AI, including generative AI, in the inventive process.
If your drug candidate is a mere obvious modification of a known product you will face an uphill battle convincing the patent office that you have a patentableinvention, regardless of whether it was derived using AI-tool or through human endeavour. Protecting the platform: To patent or trade secret? Alfie (a.k.a.
We organize all of the trending information in your field so you don't have to. Join 9,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content